Insider Trading activities of Pharmasset Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pharmasset Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Pharmasset Inc since year 2005. Table 2 shows the detailed insider transactions of Pharmasset Inc since 2005. The reporting company's ticker symbol is VRUS. The reporting company's CIK number is 1301081.
The total value of stock buying since 2005 is $15,109,837.
The total value of stock sales since 2005 is $80,537,660.
The total value of stock option exercises since 2005 is $5,068,036.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Pharmasset Inc (VRUS).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2011-12 0 $0 6,252 $814,823 6,252 $55,205
2011-11 0 $0 20,624 $1,537,725 20,624 $210,877
2011-10 0 $0 40,000 $3,173,320 40,000 $60,000
2011-09 0 $0 43,124 $2,830,055 43,124 $93,817
2011-07 0 $0 20,938 $2,314,216 20,938 $77,446
2011-06 0 $0 20,000 $2,010,700 20,000 $60,000
2011-05 0 $0 102,499 $10,497,721 70,000 $900,800
2011-04 0 $0 79,603 $7,968,996 70,103 $1,005,596
2011-03 0 $0 6,279 $401,856 6,279 $85,833
2010-12 0 $0 0 $0 43,125 $799,106
2010-10 0 $0 5,000 $147,500 0 $0
2010-09 0 $0 12,811 $377,924 62,477 $279,917
2010-07 0 $0 0 $0 7,189 $28,899
2010-06 0 $0 2,976 $96,806 0 $0
2010-03 0 $0 0 $0 1,668 $9,082
2010-01 0 $0 0 $0 7,500 $29,587
2009-12 0 $0 0 $0 1,666 $9,071
2009-09 0 $0 950,000 $20,100,540 41,666 $163,871
2009-06 0 $0 0 $0 21,666 $117,971
2009-02 3,000 $31,150 0 $0 0 $0
2008-11 0 $0 32,521 $594,806 18,750 $260,249
2008-08 0 $0 5,835 $125,411 5,835 $17,505
2008-06 0 $0 1,040,293 $20,946,502 2,976 $12,499
2008-05 0 $0 102,097 $1,810,847 102,097 $453,186
2008-04 0 $0 48,907 $978,973 38,400 $165,022
2008-03 5,000 $78,720 0 $0 0 $0
2008-02 0 $0 166,523 $3,808,939 26,666 $79,998
2007-09 0 $0 0 $0 10,000 $30,000
2007-08 0 $0 0 $0 20,833 $62,499
2007-05 1,555,552 $13,999,968 0 $0 0 $0
2007-04 111,111 $999,999 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Pharmasset Inc insiders (VRUS)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2011-12-01 Berrey M Michelle (Chief Medical Officer) Sale 6,252 130.33 814,823
2011-12-01 Berrey M Michelle (Chief Medical Officer) Option Ex 6,252 8.83 55,205
2011-11-01 Berrey M Michelle (Chief Medical Officer) Sale 3,124 74.56 232,925
2011-11-01 Berrey M Michelle (Chief Medical Officer) Option Ex 3,124 6.84 21,352
2011-11-01 Otto Michael J. (Chief Scientific Officer) Sale 17,500 74.56 1,304,800
2011-11-01 Otto Michael J. (Chief Scientific Officer) Option Ex 17,500 10.83 189,525
2011-10-03 Price P Schaefer (President & CEO) Sale 40,000 79.33 3,173,320
2011-10-03 Price P Schaefer (President & CEO) Option Ex 40,000 1.50 60,000
2011-09-01 Price P Schaefer (President and CEO) Sale 40,000 65.63 2,625,040
2011-09-01 Price P Schaefer (President and CEO) Option Ex 40,000 1.50 60,000
2011-09-01 Berrey M Michelle (Chief Medical Officer) Sale 3,124 65.63 205,015
2011-09-01 Berrey M Michelle (Chief Medical Officer) Option Ex 3,124 10.82 33,817
2011-07-01 Price P Schaefer (President and CEO) Sale 20,000 110.47 2,209,320
2011-07-01 Price P Schaefer (President and CEO) Option Ex 20,000 3.00 60,000
2011-07-01 Berrey M Michelle (Chief Medical Officer) Sale 938 111.83 104,896
2011-07-01 Berrey M Michelle (Chief Medical Officer) Option Ex 938 18.60 17,446
2011-06-01 Price P Schaefer (President and CEO) Sale 20,000 100.54 2,010,700
2011-06-01 Price P Schaefer (President and CEO) Option Ex 20,000 3.00 60,000
2011-05-09 Rogers Michael D. (Chief Development Officer) Sale 10,000 109.08 1,090,800
2011-05-09 Rogers Michael D. (Chief Development Officer) Option Ex 10,000 13.88 138,800
2011-05-06 Williamson Robert F Iii (Director) Sale 31,666 104.36 3,304,600
2011-05-06 Williamson Robert F Iii (Director) Option Ex 20,000 3.00 60,000
2011-05-06 Leutzinger Kurt (Chief Financial Officer) Sale 11,287 102.88 1,161,206
2011-05-05 Leutzinger Kurt (Chief Financial Officer) Sale 9,546 102.61 979,515
2011-05-03 Conrad Herbert J (Director) Sale 40,000 99.04 3,961,600
2011-05-03 Conrad Herbert J (Director) Option Ex 40,000 17.55 702,000
2011-04-28 Otto Michael J. (Chief Scientific Officer) Sale 9,500 99.85 948,575
2011-04-27 Rogers Michael D. (Chief Development Officer) Sale 20,000 99.00 1,980,060
2011-04-27 Rogers Michael D. (Chief Development Officer) Option Ex 20,000 13.88 277,600
2011-04-27 Berrey M Michelle (Chief Medical Officer) Sale 50,103 100.60 5,040,361
2011-04-27 Berrey M Michelle (Chief Medical Officer) Option Ex 50,103 14.53 727,996
2011-03-22 Otto Michael J. (Chief Scientific Officer) Sale 6,279 64.00 401,856
2011-03-22 Otto Michael J. (Chief Scientific Officer) Option Ex 6,279 13.67 85,833
2010-12-20 Hahn Elliot F (Director) Option Ex 43,125 18.53 799,106
2010-10-01 Otto Michael J. (Chief Scientific Officer) Sale 5,000 29.50 147,500
2010-09-30 Hahn Elliot F (Director) Option Ex 24,666 3.69 91,017
2010-09-28 Otto Michael J. (Chief Scientific Officer) Sale 12,811 29.50 377,924
2010-09-28 Otto Michael J. (Chief Scientific Officer) Option Ex 7,811 4.02 31,400
2010-09-17 Hahn Elliot F (Director) Option Ex 30,000 5.25 157,500
2010-07-01 Otto Michael J. (Chief Scientific Officer) Option Ex 7,189 4.02 28,899
2010-06-17 Berrey M Michelle (Chief Medical Officer) Sale 2,976 32.53 96,806
2010-03-03 Price Fredric D (Director) Option Ex 1,668 5.44 9,082
2010-01-25 Carney William J (Director) Option Ex 7,500 3.94 29,587
2009-12-04 Price Fredric D (Director) Option Ex 1,666 5.44 9,071
2009-09-24 Qvt Fund Lp (10% Owner) Sale 800,000 20.88 16,704,000
2009-09-23 Qvt Fund Lp (10% Owner) Sale 10,000 22.41 224,100
2009-09-22 Qvt Fund Lp (10% Owner) Sale 100,000 22.95 2,295,000
2009-09-18 Otto Michael (Exec.VP,Pharm.Research) Sale 40,000 21.94 877,440
2009-09-18 Otto Michael (Exec.VP,Pharm.Research) Option Ex 40,000 3.87 154,800
2009-09-02 Price Fredric D (Director) Option Ex 1,666 5.44 9,071
2009-06-01 Price Fredric D (Director) Option Ex 21,666 5.44 117,971
2009-02-27 Inouye Michael K (Director) Buy 1,250 10.10 12,618
2009-02-26 Inouye Michael K (Director) Buy 1,250 10.64 13,294
2009-02-25 Lubetkin Paul (Executive VP & General Counsel) Buy 500 10.48 5,238
2008-11-13 Rogers Michael D. (Chief Development Officer) Sale 16,672 18.48 305,767
2008-11-13 Rogers Michael D. (Chief Development Officer) Option Ex 16,672 13.88 231,407
2008-11-04 Rogers Michael D. (Chief Development Officer) Sale 500 18.14 9,067
2008-11-04 Rogers Michael D. (Chief Development Officer) Option Ex 500 13.88 6,940
2008-11-03 Rogers Michael D. (Chief Development Officer) Sale 1,578 18.00 28,404
2008-11-03 Rogers Michael D. (Chief Development Officer) Option Ex 1,578 13.88 21,902
2008-08-11 Otto Michael (Chief Scientific Officer) Sale 5,835 21.49 125,411
2008-08-11 Otto Michael (Chief Scientific Officer) Option Ex 5,835 3.00 17,505
2008-06-23 Evnin Luke (Other) Sale 28,937 19.97 577,871
2008-06-20 Berrey M Michelle (Chief Medical Officer) Option Ex 2,976 4.20 12,499
2008-06-19 Evnin Luke (10% Owner) Sale 155,800 19.93 3,105,717
2008-06-19 Gadicke Ansbert (Other) Sale 155,800 19.93 3,105,717
2008-06-17 Gadicke Ansbert (10% Owner) Sale 101,900 20.18 2,056,545
2008-06-16 Gadicke Ansbert (10% Owner) Sale 300,128 19.75 6,074,024
2008-06-13 Gadicke Ansbert (10% Owner) Sale 1,321 19.00 25,099
2008-06-10 Gadicke Ansbert (10% Owner) Sale 5,175 19.06 98,625
2008-06-05 Gadicke Ansbert (10% Owner) Sale 10,083 19.15 193,049
2008-05-27 Otto Michael (Chief Scientific Officer) Sale 81,264 17.67 1,435,853
2008-05-27 Otto Michael (Chief Scientific Officer) Option Ex 81,264 4.50 365,688
2008-05-19 Berrey M Michelle (Chief Medical Officer) Sale 20,833 18.00 374,994
2008-05-19 Berrey M Michelle (Chief Medical Officer) Option Ex 20,833 4.20 87,498
2008-04-07 Otto Michael (Exec.VP,Pharm.Research) Sale 100 20.00 2,000
2008-04-07 Otto Michael (Exec.VP,Pharm.Research) Option Ex 100 6.00 600
2008-04-04 Otto Michael (Exec.VP,Pharm.Research) Sale 400 20.00 8,000
2008-04-04 Otto Michael (Exec.VP,Pharm.Research) Option Ex 400 6.00 2,400
2008-04-02 Otto Michael (Exec.VP,Pharm.Research) Sale 37,900 20.02 758,833
2008-04-02 Otto Michael (Exec.VP,Pharm.Research) Option Ex 37,900 4.28 162,022
2008-04-02 Henner Dennis (10% Owner) Sale 5,390 20.00 107,800
2008-04-02 Simon Nicholas J Iii (10% Owner) Sale 5,117 20.00 102,340
2008-03-13 Leutzinger Kurt (Executive VP & CFO) Buy 1,000 16.32 16,320
2008-03-12 Leutzinger Kurt (Executive VP & CFO) Buy 4,000 15.60 62,400
2008-02-25 Carney William J (Director) Option Ex 26,666 3.00 79,998
2008-02-08 Wheeler Kurt (10% Owner) Sale 6,874 21.36 146,828
2008-02-08 Mpm Bioventures Iii Llc (10% Owner) Sale 6,874 21.36 146,828
2008-02-08 Gadicke Ansbert (10% Owner) Sale 27,925 21.36 596,478
2008-02-07 Wheeler Kurt (10% Owner) Sale 17,450 23.02 401,699
2008-02-07 Mpm Bioventures Iii Llc (10% Owner) Sale 17,450 23.02 401,699
2008-02-07 Gadicke Ansbert (10% Owner) Sale 36,664 23.02 844,005
2008-02-04 Wheeler Kurt (10% Owner) Sale 12,993 23.86 310,012
2008-02-04 Mpm Bioventures Iii Llc (10% Owner) Sale 12,993 23.86 310,012
2008-02-04 Gadicke Ansbert (10% Owner) Sale 27,300 23.86 651,378
2007-09-05 Otto Michael (Exec.VP,Pharm.Research) Option Ex 10,000 3.00 30,000
2007-08-09 Leutzinger Kurt (Executive VP & CFO) Option Ex 20,833 3.00 62,499
2007-05-02 Wheeler Kurt (10% Owner) Buy 277,777 9.00 2,499,993
2007-05-02 Mpm Bioventures Iii Llc (10% Owner) Buy 277,777 9.00 2,499,993
2007-05-02 Burrill Life Sciences Capital Fund Lp (10% Owner) Buy 222,222 9.00 1,999,998
2007-05-02 Burrill Steven (Director) Buy 222,222 9.00 1,999,998
2007-05-02 Steinmetz Michael (10% Owner) Buy 277,777 9.00 2,499,993
2007-05-02 Gadicke Ansbert (Director) Buy 277,777 9.00 2,499,993
2007-04-27 Tvm V Life Science Ventures Management Gmbh & Co. (10% Owner) Buy 111,111 9.00 999,999

Insider trading activities including stock purchases, stock sales, and option exercises of VRUS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Pharmasset Inc (symbol VRUS, CIK number 1301081) see the Securities and Exchange Commission (SEC) website.